Filing Details
- Accession Number:
- 0001645627-18-000069
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-02 16:52:16
- Reporting Period:
- 2018-10-29
- Accepted Time:
- 2018-11-02 16:52:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | No | No |
Transaction Summary
| Purchased: | 34,000 shares | Avg. Price: $0.04 | Total Value: $1,319.50 |
| Number of Shares After Transactions: | 26,124,498 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-10-29 | 2,000 | $0.04 | 26,092,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-30 | 1,000 | $0.04 | 26,093,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-30 | 2,000 | $0.04 | 26,095,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 2,000 | $0.04 | 26,097,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,098,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,099,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,100,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,101,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 2,000 | $0.04 | 26,103,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,104,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,105,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,106,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 2,000 | $0.04 | 26,108,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 2,000 | $0.04 | 26,110,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,111,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,112,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,113,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 5,000 | $0.04 | 26,118,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,119,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,120,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 1,000 | $0.04 | 26,121,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-01 | 1,000 | $0.04 | 26,122,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-01 | 1,000 | $0.04 | 26,123,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-01 | 1,000 | $0.04 | 26,124,498 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
